ZERIAZero Emission Research in Austria (Graz, Austria)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Vifor Pharma AG (VTX: VIFN) has granted Zeria Pharmaceutical Co Ltd (TYO: 4559) exclusive rights to develop and commercialise Veltassa in Japan, the global pharmaceuticals company disclosed on Tuesday.
Tillotts Pharma AG, part of the Zeria Group, is a specialty pharma company with over 200 employees in Switzerland and abroad.
Based on this agreement, Eisai will grant Zeria the exclusive rights to develop and co-promote, and the non-exclusive right to manufacture, E3710 in Japan.
In the L-NaP group, each patient ingested 5 NaP tablets (Visiclear, Zeria Pharmaceutical, Tokyo, Japan) orally every 15 min with 200 mL of clear liquid (water or green tea; total 30 tablets and 1.2 L liquid).
On the other hand, some studies reveal negative relationship between cultural differences and IJV performance (e.g., Li and Guisinger, 1991; Shenkar and Zeria, 1992; Pennings, Barkema and Douma, 1994; Hennart and Zeng, 1997; Lin and Germain, 1998; Luo and Park, 2002a; Luo and Park, 2004).
Zee has launched Zeria, a lifestyle-focused website and tapped Showtime vet Hal Rosenberg to run it.
Created by Alex Kutsy from Zeria in Tampa, Florida 1 1/2 Bombay Sapphire splash Chambord splash Frangelico splash Bacardi Vanila 1 tsp.
Marketing approval is anticipated soon for two new agents: rosuvastatin (Crestor), a drug that, like atorvastatin, lies at the high end of the LDL-lowering potency spectrum, and ezetimibe (Zeria).
In Japan, PeptoZin has been sold for over a decade as an ulcer-healing drug under the name Polaprezinc[R] (Zeria Pharmaceutical).
Of those studies that have addressed this question, most have investigated women's interest in pursuing international assignments, whether companies are reluctant to send women on these assignments, and whether women encounter prejudices in foreign cultures that negatively affect their job performance (Adler, 1984a; 1984b; 1985; Hill & Tillery, 1992; Izraeli, Banai, & Zeria, 1980; Westwood & Leung, 1994).
Companies Mentioned in this Report: Zeria Pharmaceutical Co., Ltd., AstraZeneca Plc, Astellas Pharma Inc., Novartis AG, Aptalis Pharma Inc., Eisai Co., Ltd., Dong-A Socio Group, Pfizer Inc., Ironwood Pharmaceuticals, Inc., GlaxoSmithKline Plc"